Journal
JOURNAL OF RHEUMATOLOGY
Volume 42, Issue 10, Pages 1842-1845Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.150193
Keywords
ANKYLOSING SPONDYLITIS; LIPIDS; CARDIOVASCULAR DISEASE; INFLAMMATION; ANTI-TUMOR NECROSIS FACTOR THERAPY
Categories
Ask authors/readers for more resources
Objective. To investigate the effects of changing inflammation on lipid levels in ankylosing spondylitis. Methods. In a cohort of 230 patients, lipid levels were measured at baseline and after 52 weeks of treatment with tumor necrosis factor-alpha-blocking agents (anti-TNF). Results. Total cholesterol (TC; +4.6%), low-density lipoprotein cholesterol (+4.3%), and high-density lipoprotein cholesterol (HDL-C; +3.7%) increased upon treatment. Changes were most evident in patients with substantial reduction in inflammatory levels (TC +8.2% vs +1.6% and HDL-C +8.3% vs +2.2% in patients with C-reactive protein = 10 mg/l normalizing upon treatment vs CRP < 10 mg/l throughout treatment period). Conclusion. Anti-TNF therapy results in lipid changes mostly when inflammation is appreciably modified.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available